Recent findings have established caspase-2 as an important apical regulator in apoptotic pathways leading from DNA damage to release of mitochondrial cytochrome c and subsequent activation of effector caspases. Yet, the molecular map connecting the embarking stimuli of genotoxic stress with caspase-2 activation remains to be elucidated. Here, we address the question of potential caspase-2 regulators by examining 5-fluorouracil (5-FU)-induced apoptosis in wild-type and p53-deficient human colon carcinoma cells. Apoptosis was observed only in p53 þ / þ cells and was preceded by caspase-2 activation. Hence, although no direct interaction between p53 and caspase-2 was observed in the cell system used, our data clearly demonstrate that a functional connection between these two proteins is essential for initiation of the 5-FUinduced apoptotic process. Proposed mediators of caspase-2 activation include PIDDosome complex proteins PIDD and RAIDD. Surprisingly, the presence of a complex encompassing at least RAIDD, PIDD and caspase-2 was verified in both p53 þ / þ and p53 À/À cells, also in the absence of 5-FU treatment. Thus, our results confirm the participation of PIDD and RAIDD in PIDDosome complex formation but question their role as sole mediators of caspase-2 activation. This assumption was further supported by siRNA transfections targeting PIDD or RAIDD. In conclusion, our findings support the hypothesis of p53 as an upstream regulator of caspase activity and provide data concerning caspase-2 processing mechanisms. As suppression of caspase-2 expression in 5-FU-treated cells also affects the level of the p53 protein, possibilities of a reciprocal interaction between these proteins are discussed.
Introduction
Apoptosis is a cellular self-destruction program critical during development and in maintenance of tissue homeostasis, and a key mechanism for the removal of infected, transformed or damaged cells. Regulation and execution of this controlled cascade of events are mainly accomplished by caspases, a family of cysteine proteases that cleave proteins after aspartic acid residues. To date, 14 members of this family have been identified in metazoans (Nicholson and Thornberry, 1997) . Caspases are normally sub-grouped with respect to their mode of action into either initiator or effector caspases. Caspase-1, -2, -8 and -9 are considered as initiator caspases, which also is reflected in their primary structure as they are provided with long prodomains containing characteristic protein-protein interaction motifs. In comparison, effector caspases, including caspase-3, -6 and -7, have short prodomains. In dividing cells, caspases are expressed as latent monomeric zymogens which, in response to various apoptotic stimuli, are proteolytically processed to generate dimers of identical catalytic units (Fuentes-Prior and Salvesen, 2004) .
In comparison to other initiator caspases, less is known about regulatory functions of caspase-2 during the apoptotic process. Procaspase-2 is the only procaspase that is present constitutively in the nucleus (Shikama et al., 2001) . It has also been found in cytosol, mitochondria and in the Golgi system (O'Reilly et al., 2002; Ren et al., 2005) . Gene targeting of caspase-2 in mice revealed an unexpectedly mild phenotype (Bergeron et al., 1998) , although these data may be explained by the presence of compensatory parallel pathways (Troy et al., 2001 ). This conclusion is further supported by the fact that fibroblasts lacking both caspase-2 and -9 remain sensitive to diverse apoptotic stimuli (Marsden et al., 2004) . Procaspase-2 is efficiently processed by recombinant caspase-3 in vitro and is activated downstream of caspase-3 and -9 in selected experimental settings (Harvey et al., 1996; Paroni et al., 2001) . Given that comparatively few substrates have been found for caspase-2 (Mancini et al., 2000; Rotter et al., 2004; Ho et al., 2005) , these data could be explained by the presence of an apoptotic amplifying loop involving either caspase-3 or -9 or both, in some apoptotic schemes (Wieder et al., 2001) . The fact that the caspase-2 zymogen does not require cleavage for the initial acquisition of activity further supports this paradigm (Baliga et al., 2004) .
However, recent reports have uncovered details of caspase-2 as an apical regulator, and the identification of several interactive proteins has further helped to define its role during apoptosis induced by genotoxic stress. Apart from a premitochondrial function leading to cytochrome c release and the processing of caspase-9 (Guo et al., 2002; Lassus et al., 2002; Robertson et al., 2002) , it seems that caspase-2 can directly interact with the mitochondria, and that this interaction occurs independently of its proteolytic activity (Enoksson et al., 2004; Robertson et al., 2004) . Suppression of caspase-2 by RNA interference prevents mitotic catastrophe and allows cells, in which a conflict in cell cycle progression was been introduced, to further proceed through the cell cycle (Castedo et al., 2004) . In contrast, caspase-2 is dispensable in lytic necrosis induced by arsenic trioxide demonstrating a selective implication of this enzyme in cell death processes (Scholz et al., 2005) .
Similar to other initiator caspases, the prodomain of caspase-2 is equipped with a caspase recruitment domain (CARD). Interaction with another CARDcontaining protein ARC (Koseki et al., 1998) has been demonstrated, although the functional significance of this interaction needs further investigation. More interestingly, activation of caspase-2 was found to occur in a high molecular complex containing RAIDD (RIP associated ICH1/CED3 homologous protein with DD) and death domain protein PIDD (p53-inducible protein with a DD), whose expression is regulated by p53 Tinel and Tschopp, 2004) . Analogous activation at multiprotein complexes has been verified for initiator caspases-8, -9 and -10 (Boatright and Salvesen, 2003) . Still, even if available data suggest that apical caspases are activated by adaptor-mediated clustering of inactive zymogens, apoptotic signals leading to these events remain to be identified. The identification of the PIDDosome complex suggests a link between caspase-2 and p53, a possibility which also has been suggested by Ren et al. (2005) in their report on Birc6, an upstream regulator of p53.
The aim of the current study was to further investigate the importance of p53 for caspase-2 activation in 5-FUinduced apoptosis using wild-type and p53-deficinet HCT116 human colorectal cancer cells. By this model, we show that induction of both cytochrome c release and oligonucleosomal DNA fragmentation rely on a pathway, which includes both p53 and caspase-2. Furthermore, we confirm the formation of a complex between RAIDD, PIDD and caspase-2 and provide evidence for its existence also under normal cellular conditions. Consequently, caspase-2 processing is shown to occur independently of RAIDD and PIDD in the cell system used. Our data also suggest the existence of a possible feedback loop deriving from caspase-2 with consequences for p53 expression or stabilization.
Results

Characteristics of 5-FU-induced apoptosis in human colon carcinoma HCT116 cells
In agreement with previous observations, we found that the p53 status of HCT116 cells governs their response to genotoxic stress induced by 5-FU. In contrast to p53 deficient cells, pronounced oligonucleosomal DNA fragmentation was observed in wild-type cells treated with 5-FU for 48 h (Figure 1a) . In FACS analysis of PIstained cells, accumulation of a discrete subG1/apoptotic population was seen only in p53
þ / þ cells after 24 h of 5-FU exposure (Figure 1b) . A similar pattern was obtained in FACS analysis of phosphatidylserine (PS) exposure using FITC-labeled Annexin V, showing PS exposure in B37% of p53 þ / þ cells, whereas p53 À/À cells exhibited no apparent PS exposure (Figure 1c ). Counting of cells displaying chromatin condensation using Hoechst staining further consolidated our data, revealing 5-FU as a potent inducer of apoptosis in HCT116 p53
þ / þ cells, but not in p53 À/À cells ( Figure 1d ). In addition, a reduction of apoptosis in response to 5-FU was observed by introducing the most selective caspase-2 inhibitor z-VDVAD-fmk (Figure 1b-d) . Taken together, these results clearly indicate that the apoptotic effect of genotoxic stress induced by 5-FU in HCT116 cells noticeably depends upon their p53 status, as shown by a lack of apoptotic features in p53 À/À cells. These data also suggest caspase-2 as an important apoptotic mediator of this specific pathway.
p53 is required for caspase-2 activation in HCT116 cells during 5-FU-induced apoptosis Caspase activity measurements in HCT116 cells were performed by fluorometric assays. As shown in Figure  2a and b, analysis of VDVADase and DEVDase activities indicated a time-dependent increase in both caspase-2 and -3 activities in 5-FU-treated p53 þ / þ cells, whereas little or no increase could be observed in p53 À/À cells. In agreement with our previous observations in Jurkat cells (Robertson et al., 2002) , caspase-2 appeared to be activated before caspase-3 (Figure 2a and b) . This was further supported by data showing that the stimulation of both caspase-2 and -3 activities were blocked by the selective caspase-2 inhibitor z-VDVADfmk, but only the latter was blocked using the caspase-3 inhibitor z-DEVD-fmk (Figure 2c and d) . Hence, our findings confirm the role of caspase-2 as a bona fide initiator caspase, and suggest that p53 is critical for its activation.
Caspase-2 mediates p53-dependent apoptosis in HCT116 cells Next, we analyzed mitochondrial cytochrome c and AIF release by Western blotting in p53 þ / þ and p53 À/À cells after treatment with 5-FU. Analogous to apoptotic parameters illustrated in Figure 1 , efficient release of cytochrome c was totally dependent on p53 expression and no AIF release could be detected upon 5-FU treatment in either p53
þ / þ or p53 À/À cells (Figure 3a ). Further, in immunoblot analysis, a significant reduction of cytochrome c release was seen in p53 þ / þ cells in the presence z-VDVAD-fmk, but not with z-DEVD-fmk (Figure 3b ). To further consolidate these data caspase-2 expression was suppressed by siRNA targeting of the caspase-2 mRNA (Figure 4a ). In cells containing approximately 10% of normal caspase-2 levels, a decrease in 5-FU-induced cytochrome c release, FITClabeled Annexin V staining and oligonucleosomal DNA fragmentation was detected when compared to control cells (Figure 4b and c and data not shown). Hence, these observations indicate that both p53 and caspase-2 are needed in order to complete the apoptotic process in HCT116 cells. Theses data also suggest p53 function to be upstream of caspse-2.
Analysis of RAIDD and PIDD as transitional molecules in 5-FU-induced apoptosis Our immunoprecipitation data (not shown) did not support a direct interaction between p53 and caspase-2 in 5-FU-treated HCT116 cells, suggesting that the apoptotic response might be mediated via transitional molecules. Indeed, as members of the PIDDosome complex, both RAIDD and PIDD have been proposed to accomplish this task (Tinel and Tschopp, 2004; Wang et al., 2005 ). Yet, since overexpression was used in these reports, we decided to perform a reciprocal interaction study by immunoprecipitation in nontransfected cells, incorporating caspase-2, RAIDD and PIDD. Using relevant controls (data not shown), Western blot analysis of the precipitation complex, formed by each antibody, revealed a direct interaction between all three proteins (Figure 5a-c) . Interestingly, using the caspase-2 mAb as pull-down agent, no full-length PIDD was seen in the analysis. Instead, a band that may correspond to a cleavage product, or to a splice variant, of this protein appeared (Figure 5a ) (Telliez et al., 2000) . No obvious conclusion could be drawn from comparison of samples from p53
þ / þ and 5-FU-treated p53 þ / þ cells except that the more robust complex formation seen in the p53 þ / þ cells might be indicative of an aggregating function of this protein ( Figure 5a and c, lanes 3-4). For unknown reasons, only faint bands corresponding to caspase-2 were distinguished when we examined precipitations using anti-PIDD Abs (Figure 5c ), and the presence of RAIDD was below detection level (data not shown). Further, indirect immunofluorescence in HCT116 cells, using antibodies directed to either PIDD, or RAIDD, or caspase-2, revealed a cytoplasmic colocalization of these proteins irrespective of p53 background and 5-FU treatment of cells ( þ / þ HCT116 cells. Blots were re-probed for G3PDH to confirm equal loading of the samples. p53 and Caspase-2 are essential for apoptosis H Vakifahmetoglu et al emphasized the importance of both PIDD and RAIDD for efficient caspase-2 processing (Tinel and Tschopp, 2004; Berube et al., 2005) . Nevertheless, in HCT116 wild-type cells caspase-2 processing and cytochrome c release as a consequence of 5-FU treatment were not affected by repression of endogenous PIDD or RAIDD expression ( Figure 7c ). Hence, our findings suggest that although these proteins are important for complex formation; PIDD and RAIDD are not sole mediators of caspase-2 activation.
Suppression of caspase-2 leads to upregulation of p53 during 5-FU-induced apoptosis DNA damage is usually accompanied by upregulation of p53 as a result of protein stabilization and/or transcriptional activation. Nuclear p53 accumulation subsequently stimulates expression of genes involved in cell death and cell cycle arrest (Schuler and Green, 2005) . Combined, immunoblotting and RT-PCR analysis provided evidence for protein accumulation rather than transcriptional upregulation of p53 in 5-FU-treated HCT116 cells (Figure 8a and b) . Interestingly, a weak PCR product for p53 was detected using HCT116 p53 À/À cDNA as template ( Figure 8b ). As these cells harbour a targeted deletion of exon 2 in the p53 gene, and our specific primers are within the region that is still retained, the amplification may be explained by residual silent p53 mRNA (Bunz et al., 1998) .
In agreement with previous reports (Miyashita and Reed, 1995; Lin et al., 2000; Nakano and Vousden, 2001) , the presence of p53 in 5-FU-treated cells generated elevated amounts of Bax and PUMA-a (Figure 8a ), whereas only a minor increase in PIDD could be detected at both the protein and at the mRNA levels after 24 h of 5-FU treatment (Figure 8a and b) . RAIDD expression remained unchanged. Interestingly, reduction of caspase-2 content by siRNA in 5-FUtreated cells led to even higher levels of p53 compared to samples treated with 5-FU alone. This effect was paralleled by a decrease in the amount of Bax, and an increase in PUMA-a level, whereas RAIDD remained unaffected (Figure 9a) . A similar effect on p53 accumulation could be seen using the caspase-2 selective inhibitor zVDVAD-fmk, whereas no effect of the caspase-3 inhibitor zDEVD-fmk could be detected (Figure 9b ). During identical experimental conditions, zVDVAD-fmk also resulted in increased amounts of PIDD (Figure 9c ). These observations indicate a bidirectional functional influence between p53 and caspase-2, which is also affecting the expression of Bax, PIDD and PUMA-a. However, further investigations are required for a more comprehensive understanding of these findings.
Discussion
It is well established that the p53 tumor suppressor gene is critical for the cellular response to DNA damage and apoptotic outcome. Its significance for the activation of caspases in general, and caspase-8 in particular, has previously been shown (Ding et al., 2000; Schuler et al., 2000) . In the present study, we found that p53 is fundamental for both caspase-2 activation and for further completion of the apoptotic process in 5-FUtreated colon carcinoma cells.
To fully understand the molecular mechanisms underlying these observations is undoubtedly a more demanding challenge. However, immunoprecipitation experiments demonstrated an association of caspase-2, PIDD and RAIDD. Interactions between these proteins were observed in untreated as well as in 5-FU-induced HCT116 cells, suggesting spontaneous interaction of caspase-2, PIDD and RAIDD also under normal cell conditions. PIDD has been implicated in caspase-2 activation (Tinel and Tschopp, 2004) , whereas a detailed function for the RAIDD-caspase-2 interaction remains to be defined. Also the subcellular localization of these interactions needs further attention. Owing to the presence of CARD domains, overexpression of either RAIDD or caspase-2 results in aggregate formation. As large protein complexes could interfere with normal protein distribution and nucleo-cytoplasmic transport, , 2005) . A strong nuclear localization signal in the prodomain of caspase-2 has been described (Baliga et al., 2003) . However, our findings showing caspase-2 mainly in the cytoplasm support the view that the regulation of the nucleocytoplasmic transport of this protein is more complex than previously thought (Ren et al., 2005) . Of interest is also the translocation of caspase-2 to promyelocytic leukemia protein nuclear bodies (PML-NBs) during DNA damage-induced apoptosis, which seems to be independent of RAIDD (Tang et al., 2005) . A marked upregulation in the amount of p53 in response to 5-FU treatment resulted in an insignificant elevation of PIDD, both at the protein and transcriptional levels. It is questionable how this minor transcriptional activation can have such a dramatic impact on apoptotic behavior in HCT116 cells. The results rather argue for a scenario where the p53 -caspase-2 apoptotic circuit is mediated by a still unidentified molecule in the PIDDosome complex, or by an alternative pathway of caspase-2 activation. This assumption was primarily supported by siRNA targeting of PIDD or RAIDD, but also by data showing complex formation between PIDD, caspase-2 and RAIDD irrespective of 5-FU treatment. This is in sharp contrast to recent reports concerning function of the PIDDosome complex (Tinel and Tschopp, 2004; Berube et al., 2005) . A number of possible justifications for this inconsistency exist. Firstly, nonphysiological conditions such as PIDD overexpression or in vitro incubation of cell extracts were used in previous studies to elucidate PIDDosome function. Secondly, DNA-damage-induced NF-kB activation depends on the PIDDosome due to incorporation of key regulatory proteins RIP1 and NEMO, a conduit in which caspase-2 seems to be inactive (Janssens et al., 2005) . Hence, the function for the PIDDosome complex is dual, and each function may þ / þ cells. G3PDH was used as control for equal loading of the samples. 2) ; 5-FU-treatment (lanes 3 and 4).
-G3PDH -p53 53 kDa -37 kDa - þ / þ cells incubated in the presence of either zVDVAD-fmk or zDEVD-fmk for 24 h. G3PDH was used as a control for equal loading of the samples. p53 and Caspase-2 are essential for apoptosis H Vakifahmetoglu et al processing disclosed. Finally, very recently the crystal structure of the RAIDD death domain at 2 Å resolution was reported and revealed important features of this protein for assembly of the PIDDosome complex (Park and Wu, 2006) . Altogether, it seems that both PIDD and RAIDD are essential for formation of the PIDDosome complex together with procaspase-2, but that some additional factor(s) are required for caspase-2 processing/activation.
There is no evidence for transcriptional activation of the caspase-2 gene in response to 5-FU, or to any other genotoxic agents. Still, our findings of increased amounts of p53 and PUMA-a, together with a decreased level of Bax, upon 5-FU treatment of cells in which caspase-2 had been downregulated, are remarkable in a wider perspective. Hence, they clearly stress the importance of a balance between genes included in the apoptotic process. Further, they question the current assumption of a unidirectional p53-caspase cascade. As the control experiments demonstrated that RNA interference per se was not sufficient to increase p53 protein level, caspase-2 could be linked to regulating factors upstream of p53. Potential candidates include Birc6 (Bruce), an inhibitor of apoptosis protein (IAP), which antagonizes cell death by suppressing caspases, and Bcl-2. Ren et al. (2005) reported that silencing of endogenous Birc6 mRNA by siRNA was sufficient to activate p53, which further provoked Bax upregulation and caspase-2 processing. Bcl-2 suppresses p53-dependent apoptosis constitutively in colorectal cancer cells and has the ability to regulate caspase-2 activity (Jiang and Milner, 2003; Lin et al., 2005) . Alternatively, given that inhibition of caspase-2 proteolytic activity promotes p53 upregulation in 5-FU-treated cells, the results may be explained by involvement of caspase-2 in the turnover of p53. Notably, the effect was absent in samples treated with the caspase-3-like inhibitor zDEVD-fmk, thus excluding this route from possible caspase-2 -p53 interaction pathways. p53 levels and activities are kept under tight control by an intricate network of activators and inhibitors (Levav-Cohen et al., 2005) . At present, we are unable to decide whether the caspase-2 regulatory function of p53 primarily occurs during normal or apoptotic cellular conditions. The physiological context for our findings is currently investigated.
Throughout our study, processing of caspase-2 is displayed by means of the 31 kDa intermediate band. Nevertheless, complete processing to the p18/p12 subunits could be detected via overexposure of films. In the system described, it is therefore unlikely that acquisition of activity is separated from processing as demonstrated by Baliga et al. (2004) .
A recent report revealed the requirement of p53 and caspase-2 for translocation of AIF from the mitochondria to the nuclei in cisplatin-treated renal tubular epithelial cells (Seth et al., 2005) . However, in our experimental system release of cytochrome c, but not AIF, was documented. Moreover, it was previously demonstrated by us that fully processed caspase-2 stimulates the release of cytochrome c and Smac/ DIABLO, but not AIF, upon incubation with isolated mitochondria or digitonin-permeabilized cells. This occurred independently of several Bcl-2 family proteins, and inactivation experiments revealed that the proteolytic activity of caspase-2 is not required for the effect (Enoksson et al., 2004) . In conclusion, our study manifests the p53 -caspase-2 apoptotic axis as fundamental for efficient cell death induced by genotoxic stress and introduces a new link leading from caspase-2 activity to p53 regulation.
Materials and methods
Cell culture
The parental human colon carcinoma cell line, HCT116, and its derivate, deficient in p53 mRNA expression, were cultured in DMEM complete medium supplemented with 10% heat-inactivated fetal calf serum, penicillin (100 U/ml) and streptomycin (100 mg/ml). Cells were cultured in a humidified 5% CO 2 -atmosphere at 371C and maintained in a logarithmic growth phase for all experiments. In all experiments, apoptosis was induced with 5-fluorouracil (375 mM) (Sigma-Aldrich, St Louis, MI, USA). In selected samples, the irreversible caspase-2 inhibitor z-VDVAD-fmk (25 mM) and caspase-3-like inhibitor z-DEVD-fmk (10 mM) (Enzyme Systems Products, Livermore, CA, USA) were added 1 h in advance of experimental set off. All cell culture reagents were purchased from Gibco BRL, unless otherwise stated.
Mitochondrial cytochrome c release Cells (1 Â 10 6 ) treated as indicated in figures were washed once in ice-cold phosphate-buffered saline (PBS), resuspended in 100 ml of buffer (5 mM Tris-HCl, pH 7.4, 50 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, 5 mM succinate, 1 mM KH 2 PO 4 , 140 mM manitol), and permeabilized with digitonin (10 mg) for 5 min at room temperature (RT). Mitochondria and nuclei were removed from the soluble cytosolic fraction by centrifugation at 16 000 g for 5 min. Mitochondrial pellets and supernatants containing released cytochrome c were subsequently separated in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and analysed by immunoblotting.
Analysis of phosphatidylserine exposure and propidium iodide staining Phosphatidylserine exposure on the outer leaflet of the plasma membrane was detected using the Annexin V-FITC Apoptosis Detection Kit II (BD Biosciences, Stockholm, Sweden), according to the manufacturer's instructions. In brief, following 5-FU treatment, 5 Â 10 5 cells were washed once in cold PBS and resuspended in 100 ml of binding buffer containing an Annexin V-FITC-propidium iodide mixture (PI). Before FACS analysis, an additional 400 ml of binding buffer were added to the cell suspension. Necrotic cells were excluded by gating before analysis and never accounted for more than 4% of total cells. For PI staining of the subdiploid cell population cells was incubated overnight at 41C in PI-buffer (PI (50 mg/ ml), 0.1% Triton X-100 and 0.1% sodium citrate). FACS analysis was performed using the FACScan system and the CellQuest pro software (BD Biosciences). 
Immunofluorescence
DNA fragmentation
Analysis of oligonucleosomal DNA fragmentation was performed by resuspension of 2 Â 10 6 cells, previously washed once in PBS, in 500 ml lysis buffer (100 mM Tris-HCl, pH 8.5, 5 mM EDTA, 0.2 M NaCl, 0.2% SDS and 0.1 mg/ml proteinase K). After overnight incubation, DNA was precipitated by adding an equal volume of isopropanol, dissolved in 50 ml TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) containing 0.1 mg/ml RNase A, and further incubated at 371C for 30 min in order to degrade contaminating mRNA. DNA samples were mixed with 6 Â Loading Dye Solution (Fermentas, Vilnius, Lithuania) and separated in 2% agarose gels. The DNA marker VI (Roche Diagnostics, Bromma, Sweden) served as a molecular marker.
Reverse transcriptase-polymerase chain reaction Total RNA was isolated from induced and noninduced cells by taking advantage of the RNAeasy mini kit (Qiagen, Hilden, Germany). RNA quality was controlled by separation of 18S and 28S ribosomal RNA in denaturing agarose gel electrophoresis and by visualization through ethidium bromide staining. For first strand cDNA synthesis, the RevertAidt M-MuL V RT enzyme (Fermentas) was used in combination with an oligo(dT) 18 primer, and according to the instructions of the manufacturer. The PCR were performed using the Platinum s Pfx DNA polymerase system (Invitrogen, Stockholm, Sweden) and the following specific primers (Thermo Hybaid, Middlesex, UK): PIDD (forward primer (fp), ACC AGTGGCAGCCCTCATTC; reverse primer (rp), TGACC GGTTGGAAGCTG), p53 (fp, ACCAGGGCAGCTACGG TTTC; rp, CCTGGGCATCCTTGAGTTCC), G3PDH (fp, CCTGGCCAAGGTCATCCATG; rp, TGAGGTCCACCC TGTTG). The conditions for all PCR reactions were as follows: 941C for 1 min (hot start) followed by 951C for 15 s, 601C for 30 s and 681C for 50 s. Samples were removed every five cycle to ensure exponential product growth. Polymearse chain reaction (PCR) yield was analysed on a 2% agarose gel.
Gel electrophoresis and immunoblotting
Cells were harvested, washed in PBS and lysed for 30 min on ice in lysis buffer (20 mM Tris-HCl, pH 8.0, 2 mM EDTA, 138 mM NaCl, 10% glycerol 1% Triton X-100 and 1 Â Complete protease inhibitors (Roche Diagnostics)). Equal amounts of protein from each sample were mixed with Laemmli's loading buffer, boiled for 5 min, and subjected to SDS-PAGE at 130 V followed by electroblotting to nitrocellulose membranes for 2 h at 100 V. Membranes were blocked for 1 h with 5% non-fat milk and 2% BSA in PBS at RT and subsequently probed with the primary antibody of interest. Blots were revealed by ECLt (Amersham Biosciences).
Antibodies
Primary antibodies used in Western blotting: anti-p53 mAb, clone 184721 (R&D systems, Minneapolis, MN, USA); anticytochrome c mAb, clone 7H8.2C12 (BD Biosciences); antiBax mAb, clone 6A7 (BD Biosciences); anti-RAIDD mAb, clone Raiddy-1 (Alexis Biochemicals, Lausanne, Switzerland); polyclonal antibody raised against PIDD-DD (776-910) (kindly provided by Professor Ju¨rg Tschopp, University of Lausanne); anti-caspase-2 mAb, clone 35 (BD Biosciences); polyclonal anti-PUMA (Cell Signalling); polyclonal anti-G3PDH serum (Nordic Biosite, Ta¨by, Sweden). All primary antibodies were diluted in PBS containing 1% bovine serum albumin and 0.1% NaN 3 . Secondary antibodies were diluted in blocking buffer. Horseradish-peroxidase-conjugated secondary antibodies were purchased from PIERCE. Antibodies used in immunoprecipitation: anti-caspase-2 mAb, clone 11B4 (Apotech, Epalinges, Switzerland). Antibodies directed to PIDD and RAIDD are described in the preceding paragraph.
Measurement of caspase-2 and -3-like activities
The measurement of caspase substrate (Peptide Institute, Osaka, Japan) cleavage was carried out as follows. 5 Â 10 5 cells were washed once with ice-cold PBS, resuspended in 25 ml of PBS and added to a microtiter plate. Next, cells were combined with either VDVAD-AMC (50 mM) or DEVD-AMC (50 mM), dissolved in standard reaction buffer (100 mM Hepes, pH 7.25, 10% sucrose, 10 mM DTT, 0.1% CHAPS) or (100 mM MES, pH 6.5, 10% polyethylene glycol, 10 mM DTT, 0.1% CHAPS), respectively. Cleavage of the fluorogenic peptide substrate was monitored by AMC liberation in a Fluoroscan II plate reader (Thermo Electron Co., Waltham, MA, USA) using 355 nM excitation and 460 nM emission wavelengths. Fluorescence units were converted to pmol of AMC using a standard curve generated with free AMC. Data from duplicate samples were then analysed by linear regression.
siRNA methodology Post-transcriptional caspase-2 silencing in HCT116 cells was achieved by transfection of 21-nucleotide RNA duplexes. Design and synthesis of RNA strands were performed by EiRx Therapeutics (Cork, Ireland), unless otherwise stated. Transfection of anti-caspase-2 (sense-acgaggttcctggtacatc-tt), anti-PIDD (Tinel and Tschopp, 2004) , SMARTpool anti-RAIDD (Dharmacon, Lausanne, Switzerland) and control (senseugagaaugugaugcgcguc-tt) siRNA were carried out using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions and using 100 mM of doublestranded siRNA. The quantity of caspase-2, PIDD and RAIDD in targeted cells was monitored by SDS-PAGE. Protein downregulation was confirmed as early as 24 h after transfection and lasted for up to 5 days. p53 and Caspase-2 are essential for apoptosis H Vakifahmetoglu et al Immunoprecipitation 5-FU-treated and untreated HCT116 cells were lysed on ice for 15 min in NP-40 buffer (50 mM Tris-HCL, pH 8.0, 150 mM NaCl, 1% NP-40), supplemented with PMSF (0.1 mg/ml) (Roche Diagnostics). After sonication and removal of particulate matter by centrifugation, samples were diluted to 1 mg total protein/ml using NP-40 buffer. Preclearing of lysates was performed using Protein G Sepharose 4 Fast Flow (Amersham Biosciences). Next, 1 mg of protein extract was incubated on ice with 2 mg of antibody, followed by capture with Protein G Sepharose and boiling in SDS-PAGE sample buffer.
Abbreviations 5-FU, 5-fluorouracil; DD, death domain; CARD, caspase recruitment domain; FACS, fluorescence-activated cell sorting; fmk, fluoromethyl ketone; PS, phosphatidylserine; PI, propidium iodide; DAPI, 4 0 ,6-Diamidine-2 0 -phenylindole dihydrochloride.
